8 Moore Drive
Durham, NC 27709
United States
877 495 0816
https://www.fortrea.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 17,460
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Thomas H. Pike | CEO, President & Chairman | 2.19M | N/A | 1959 |
Ms. Jill McConnell | Chief Financial Officer | 735.39k | N/A | 1975 |
Mr. Mark A. Morais | COO & President of Clinical Services | 732.47k | N/A | 1977 |
Amanda M. Warren | Chief Accounting Officer | N/A | N/A | N/A |
Ms. Hima B. Inguva | Head of Investor Relations & Corporate Development | N/A | N/A | N/A |
Stillman Hanson | General Counsel & Corporate Secretary | N/A | N/A | N/A |
Dr. John J. Doyle | President of Consulting | N/A | N/A | N/A |
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Fortrea Holdings Inc.’s ISS governance QualityScore as of 1 May 2024 is 6. The pillar scores are Audit: 6; Board: 7; Shareholder rights: 5; Compensation: 8.